Key insights
- Teradyne's president sold $73k in stock amid a significant price surge. The sale was under a pre-arranged plan. InvestingPro suggests the stock is overvalued. Aletheia noted a rebound in Taiwan's tester imports, while Morgan Stanley and Cantor Fitzgerald raised their price targets, citing networking growth and AI transformation, respectively. Overall, the insider selling and overvaluation signal slightly bearish sentiment, offset somewhat by positive analyst outlooks.
Regan Mills, President, Product Test at Teradyne (NASDAQ:TER), sold 252 shares of common stock on April 2, 2026, for $73,301. The price per share for the sale was $290.88. The transaction comes as Teradyne shares trade at $309.61, reflecting a remarkable 314% return over the past year and a 113% gain in the last six months.
According to a Form 4 filing with the Securities and Exchange Commission, Mills also disposed of 222 shares on April 1, 2026. These shares, valued at $69,308, were withheld by Teradyne to cover tax obligations related to the vesting of restricted stock units. The price per share for this transaction was $312.20.
The sale was executed under a pre-arranged trading plan intended to comply with Rule 10b5-1. According to InvestingPro analysis, Teradyne currently appears overvalued based on its Fair Value assessment, with the stock trading at a P/E ratio of 88.68. Following these transactions, Mills directly owns 11,415.3452 shares of Teradyne.
In other recent news, Teradyne Inc. announced the launch of two new platforms aimed at enhancing manufacturing processes. The Photon 100 is an automated test platform for silicon photonics and co-packaged optics manufacturing, designed to support high-volume production. Additionally, Teradyne introduced Omnyx, a test platform for printed circuit board assemblies and sub-assemblies, focusing on AI and data center applications. Both platforms integrate advanced testing capabilities to address manufacturing challenges.
Meanwhile, Aletheia issued a positive outlook on Teradyne stock, citing a rebound in Taiwan’s tester imports, driven by large orders from KYEC. In analyst updates, Morgan Stanley raised its price target for Teradyne to $306, maintaining an Equalweight rating, due to stronger networking growth forecasts. Cantor Fitzgerald also increased its price target to $330, highlighting Teradyne’s business transformation towards artificial intelligence, which now constitutes a significant portion of its revenue. These developments reflect ongoing shifts and advancements within Teradyne’s operational and strategic focus.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.